Delivery Order SPE2DB25D9317-SPE2DB25FVGGA
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,466.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 27, 2024, is for the delivery of IOSAT 130 MG TABLET 14S, a pharmaceutical product. This award is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,612.80 by the Defense Logistics Agency on August 12, 2025, for IOSAT 130 mg tablets (14-count package). This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program, valued at approximately $500 million and...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed-price delivery order contract worth $13,708.97 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of IOSAT 130 MG TABLET 14S, with a completion date of February 12, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 under the SPE2DB program, which has a total potential...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $7,844.17 firm fixed-price delivery order for the supply of IOSAT 130 MG TABLET 14S, a specialized pharmaceutical product, with a performance period ending on December 6, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,612.80 by the Defense Logistics Agency on August 15, 2025. The delivery order, which is for Iosatâ„¢ 130 mg tablets (14-count packaging), is scheduled for completion by August 18, 2025, with performance taking place at the contractor's Park Ridge facility. This award was made without a set-aside designation, allowing DMS...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,996.50 firm fixed-price delivery order (SPE2DX25F6YXR) is for the provision of IOSAT 130 MG TABLET 14S, a specialized pharmaceutical product, with a period of performance through February 24, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,099.65 firm fixed-price delivery order is for the supply of the pharmaceutical product IOSAT 130 MG TABLET 14S. The contract has an ultimate completion date of June 24, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,263.40 firm fixed-price delivery order is for the supply of 4566788078 IOSAT 130 MG TABLET 14S, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation, allowing DMS...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $16,632.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on July 23, 2025, represents one of numerous task orders issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $500 million through November 2026....
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,398.60 contract is for the delivery of IOSAT 130 MG TABLET 14S and has an August 22, 2023 completion date. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics...
- SPE2DB25D9317Indefinite Delivery Contract
- SPE2DB25D9317-SPE2DB25FVGGADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,016.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of IOSAT 130 mg tablets in quantities of 14. The contract, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a firm fixed-price model with no set-aside designation. This delivery order is executed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in government procurement markets. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare sites. With consistent contract awards from the DLA across its SPE2DB program spanning numerous medication categories—from specialty oncology treatments to vaccines and contraceptive devices—the vendor demonstrates a robust portfolio of federal pharmaceutical delivery capabilities that directly support the medical readiness of military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/25/25 |